Relay Therapeutics, Inc. Common Stock

RLAYNASDAQ

Healthcare · Biological Products, (no Diagnostic Substances)

Market cap

$3.14B

Employees

192

Exchange

NASDAQ

Headquarters

CAMBRIDGE, MA

About Relay Therapeutics, Inc. Common Stock

Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process and bringing life-changing therapies to patients. The Dynamo platform of the company integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-8186, RLY-2608, RLY-4008 and others.

Industry

Biological Products, (no Diagnostic Substances)

Sector

Healthcare

Country

US

Website

www.relaytx.com